past
month
respirolog
publish
seri
excel
review
outlin
challeng
respiratori
infect
continu
pose
asiapacif
region
beyond
world
respiratori
infect
evermov
landscap
develop
new
strategi
target
pathogen
return
exist
pathogen
adapt
new
pathogen
aris
equal
becom
awar
respiratori
infect
pose
acut
health
emerg
also
contribut
substanti
advers
longterm
health
outcom
tuberculosi
possibl
largest
killer
human
be
histori
gener
wellcontrol
sinc
western
countri
dheda
et
al
point
review
explos
drugresist
tuberculosi
undermin
control
effort
larg
area
africa
asian
subcontin
respons
death
spread
multidrugand
extens
drugresist
tuberculosi
pose
global
threat
health
new
drug
bedaquilin
delamanid
develop
sustain
effect
antibiot
threaten
haphazard
use
therefor
given
major
area
current
controversi
dheda
et
al
argu
outcom
treatment
multidrugresist
mdr
tuberculosi
poor
may
uneth
withhold
bedaquilin
regardless
concern
develop
resist
equal
argu
resourc
desper
need
adequ
control
tuberculosi
especi
drugresist
diseas
develop
world
contrast
develop
world
problem
rodrigotroyano
sibila
review
increas
problem
mdr
gramneg
bacteria
mdrgnb
problem
mostli
seen
tertiari
set
advanc
economi
rather
poverti
malnutrit
overcrowd
drive
problem
tuberculosi
frequent
use
misus
broadspectrum
antibiot
patient
fundament
inabl
resist
infect
sever
chronic
obstruct
airway
diseas
bronchiectasi
cystic
fibrosi
major
organ
failur
requir
prolong
stay
intens
care
unit
respons
mdrgnb
rodrigotroyano
sibila
point
unlik
tuberculosi
littl
progress
antibiot
develop
mdrgnb
case
report
increas
panresist
organ
immun
known
therapi
newer
antibiot
desper
need
import
factor
rodrigotroyano
sibila
focu
key
role
effect
antibiot
stewardship
appropri
endoflif
care
reduc
select
pressur
mdr
pathogen
asiapacif
region
divers
peopl
cultur
climat
therefor
differ
respiratori
infect
challeng
touch
sever
review
especi
shindo
hasegawa
point
preval
drugresist
pathogen
patient
pneumonia
enorm
variabl
within
region
rang
publish
studi
rang
relianc
guidelin
publish
countri
without
consider
local
aetiolog
recip
disast
aston
also
point
syndrom
pneumonia
need
differ
approach
develop
economi
compar
develop
one
first
possibl
tuberculosi
andor
human
immunodefici
viru
infect
usual
major
factor
develop
economi
alway
potenti
problem
second
mani
tool
treat
pneumonia
develop
economi
test
develop
countri
lim
siow
note
addit
tuberculosi
tropic
countri
spectrum
pathogen
pneumonia
includ
diseas
scrub
typhu
leptospirosi
chikungunya
dengu
well
parasit
pneumonia
overal
strong
messag
clinician
must
awar
caus
pneumonia
local
area
reli
guidelin
elsewher
even
develop
economi
may
subgroup
popul
risk
differ
spectrum
respiratori
infect
basnayak
et
al
highlight
fact
point
high
rate
bronchiectasi
indigen
popul
major
factor
high
rate
bronchiectasi
indigen
peopl
greater
burden
respiratori
infect
especi
pneumonia
relat
rel
econom
social
depriv
compar
rest
popul
good
exampl
new
pathogen
threaten
global
scene
cover
two
review
hui
et
al
review
current
data
emerg
influenza
virus
asiapacif
region
especi
avian
influenza
yin
wunderink
cover
sever
coronaviru
infect
middl
east
respiratori
syndrom
sever
acut
respiratori
syndrom
review
import
lesson
need
approach
manag
inevit
futur
viral
pandem
two
review
focus
improv
patient
outcom
pneumonia
hadfield
bennett
argu
welldefin
bundl
care
associ
best
patient
outcom
includ
rapid
guidelineconcord
antibiot
probabl
combin
betalactam
macrolid
earli
treatment
comorbid
includ
glucos
electrolyt
stabil
adequ
venou
thromboprophylaxi
earli
mobil
mecham
et
al
explor
increas
use
technolog
improv
patient
outcom
especi
clinic
decis
support
tool
number
problem
barrier
widespread
adopt
technolog
discuss
author
paint
optimist
pictur
computeraid
decisionmak
reduc
clinic
variat
improv
patient
outcom
longterm
advers
health
outcom
pneumonia
increasingli
recogn
report
review
restrepo
rey
outlin
extens
literatur
excess
cardiovascular
diseas
patient
communityacquir
pneumonia
cap
area
need
urgent
research
defin
therapi
reduc
longterm
morbid
mortal
cap
survivor
amongst
gener
concern
develop
antibiot
resist
emerg
new
threat
finch
et
al
also
paint
optimist
pictur
signific
advanc
understand
pathobiolog
infecti
diseas
past
decad
promis
come
next
one
particular
argu
omic
revolut
begin
unlock
understand
hostpathogen
interact
level
new
therapeut
strategi
emerg
hope
reader
enjoy
seri
much
well
provid
new
clinic
insight
mani
observ
author
made
gap
knowledg
provid
new
idea
challeng
research
hope
optim
finch
et
al
mecham
et
al
realiz
help
us
meet
challeng
natur
come
come
decad
grant
water
mbb
phd
school
medicin
univers
western
australia
perth
wa
australia
